Ignite Creation Date:
2025-12-24 @ 1:58 PM
Ignite Modification Date:
2026-01-23 @ 11:30 AM
Study NCT ID:
NCT00111995
Status:
COMPLETED
Last Update Posted:
2008-08-08
First Post:
2005-05-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving Hemodialysis
Sponsor:
Amgen
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
20010125
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Global Development Leader
Old Organization:
Amgen Inc.